Skip to Content
Merck
CN

Estrogen Regulates the Satellite Cell Compartment in Females.

Cell reports (2019-07-11)
Brittany C Collins, Robert W Arpke, Alexie A Larson, Cory W Baumann, Ning Xie, Christine A Cabelka, Nardina L Nash, Hanna-Kaarina Juppi, Eija K Laakkonen, Sarianna Sipilä, Vuokko Kovanen, Espen E Spangenburg, Michael Kyba, Dawn A Lowe
ABSTRACT

Skeletal muscle mass, strength, and regenerative capacity decline with age, with many measures showing a greater deterioration in females around the time estrogen levels decrease at menopause. Here, we show that estrogen deficiency severely compromises the maintenance of muscle stem cells (i.e., satellite cells) as well as impairs self-renewal and differentiation into muscle fibers. Mechanistically, by hormone replacement, use of a selective estrogen-receptor modulator (bazedoxifene), and conditional estrogen receptor knockout, we implicate 17β-estradiol and satellite cell expression of estrogen receptor α and show that estrogen signaling through this receptor is necessary to prevent apoptosis of satellite cells. Early data from a biopsy study of women who transitioned from peri- to post-menopause are consistent with the loss of satellite cells coincident with the decline in estradiol in humans. Together, these results demonstrate an important role for estrogen in satellite cell maintenance and muscle regeneration in females.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-Laminin antibody produced in mouse, clone LAM-89, ascites fluid
Sigma-Aldrich
2-Methylbutane, ReagentPlus®, ≥99%
Sigma-Aldrich
Anti-Laminin antibody produced in rabbit, 0.5 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Tamoxifen, ≥99%
Roche
In Situ Cell Death Detection Kit, Fluorescein, sufficient for ≤50 tests, suitable for detection